Codiak BioSciences Total Non Current Liabilities 2011-2025 | CDAK

Annual Total Non Current Liabilities Codiak BioSciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	119 M	74.3 M	732 K	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
119 M	732 K	64.7 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.75	-0.94 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	5.95 M	$ 3.03	-0.49 %	$ 234 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 1.17	-	$ 6.38 M	China
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Ascendis Pharma A/S ASND	101 M	$ 208.75	-1.91 %	$ 5 B	Danmark
Aptevo Therapeutics APVO	5 M	$ 0.58	-37.63 %	$ 160 K	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.16	2.1 %	$ 7.6 B	Australia
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
BioVie BIVI	62.5 K	$ 1.2	-5.51 %	$ 1.77 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.22	25.2 %	$ 479 M	Israel
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	341 M	$ 94.36	-0.71 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 26.9	0.34 %	$ 1.3 B	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Anika Therapeutics ANIK	26.1 M	$ 9.52	0.42 %	$ 140 M	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	107 M	$ 585.83	-0.9 %	$ 44.4 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.5	-1.17 %	$ 15.7 M	USA
AstraZeneca PLC AZN	30.8 B	$ 92.67	0.24 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	981 K	$ 12.47	0.81 %	$ 821 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 26.24	-2.2 %	$ 1.69 M	USA
Cellectar Biosciences CLRB	422 K	$ 2.56	-7.25 %	$ 31.3 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 10.82	0.14 %	$ 700 M	USA
Biogen BIIB	9.03 B	$ 175.8	-0.3 %	$ 25.6 B	USA
Cerevel Therapeutics Holdings CERE	4.4 M	-	-	$ 7.29 B	USA